Literature DB >> 3114834

Cholecystokinin induces the interaction of its receptor with a guanine nucleotide binding protein.

J A Williams, D J McChesney.   

Abstract

To evaluate the relation between the pancreatic cholecystokinin (CCK) receptor and guanine nucleotide-binding protein(s) we studied the effects of nucleotides on 125I-CCK binding to pancreatic acinar plasma membranes, 125I-CCK binding to solubilized 125I-CCK receptors, and the stability of the solubilized 125I-CCK-receptor complex. In plasma membranes, guanine nucleotides both inhibited CCK binding and increased the dissociation of CCK from its receptor. The potency of the nucleotides studied was GTP gamma S = GMP-PNP greater than GTP much greater than ATP. When membranes were solubilized with digitonin, subsequent binding of CCK was insensitive to guanine nucleotides including GTP, GMP-PNP and GTP gamma S. However, if CCK binding occurred before solubilization of the membranes, guanine nucleotides increased dissociation at concentrations and with a specificity similar to that observed for effects on intact pancreatic membranes. It is concluded that guanine nucleotides act via a protein which is separable from the receptor to induce dissociation of bound CCK. Moreover, CCK binding induces an association in the plasma membrane of the CCK receptor with this guanine nucleotide binding protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114834     DOI: 10.1016/0167-0115(87)90041-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  2 in total

1.  Novel tool for the study of cholecystokinin-stimulated pancreatic enzyme secretion.

Authors:  H Y Gaisano; U G Klueppelberg; D I Pinon; M A Pfenning; S P Powers; L J Miller
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Direct demonstration of three different states of the pancreatic cholecystokinin receptor.

Authors:  V D Talkad; K P Fortune; D A Pollo; G N Shah; S A Wank; J D Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.